Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance.
Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   01/01/2018 - 06/30/2018
Lobbyist name Kristina Ragosta Arnoux   
Business name CVS Health
Address 1 CVS Drive    MC 1171
City, state, zip code Woonsocket, RI 02895         
Country US
Agent type Both
Phone 401-374-4983
 
 
Operating Expenses
DateRecipientType of expenseAmount
1/1/2018-6/30/2018 Advertising expenses $0.00
1/1/2018-6/30/2018 Photocopies, scans $0.00
1/1/2018-6/30/2018 Computer equipment, supplies $0.00
1/1/2018-6/30/2018 Professional dues $0.00
1/1/2018-6/30/2018 Fax charges $0.00
1/1/2018-6/30/2018 Internet fees $0.00
1/1/2018-6/30/2018 Legal fees $0.00
1/1/2018-6/30/2018 Postage, shipping, delivery $0.00
1/1/2018-6/30/2018 Office supplies, equipment $0.00
1/1/2018-6/30/2018 Printing expenses $0.00
1/1/2018-6/30/2018 Public relations expenses $0.00
1/1/2018-6/30/2018 Rent $0.00
1/1/2018-6/30/2018 Office and support staff salaries $0.00
1/1/2018-6/30/2018 Professional subscriptions $0.00
1/1/2018-6/30/2018 Taxes $0.00
1/1/2018-6/30/2018 Telephone, cell phone, handheld $0.00
1/1/2018-6/30/2018 Utilities (heat, water, electricity) $0.00
1/1/2018-6/30/2018 Other operating expenses $0.00
  Total operating expenses $0.00
 
Activities, Bill Numbers and Titles
Client: CVS Health
Total amount paid by client; lobbyist is unable to report compensation at activity level: $7,250.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2202 An Act furthering health empowerment and affordability by leveraging transformative health care. Neutral $0.00 N/A
Senate Bill 2108 An Act relative to consumer protection for prescription drug purchases Neutral $0.00 N/A
House Bill 3448 An Act making appropriations for fiscal year 2017 to provide for supplementing certain existing appropriations and for certain other activities and projects Neutral $0.00 N/A
Senate Bill 635 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Neutral $0.00 N/A
House Bill 3582 An Act prohibiting certain pharmacy claims fees Neutral $0.00 N/A
House Bill 1195 An Act protecting children from harmful diet pills and muscle-building supplements Neutral $0.00 N/A
Senate Bill 652 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Neutral $0.00 N/A
Senate Bill 662 An Act relative to mandatory prescription drug coverage Neutral $0.00 N/A
House Bill 492 An Act to reduce health care costs through improved medication management Neutral $0.00 N/A
House Bill 3223 An Act to promote transparency in prescription drug prices Neutral $0.00 N/A
House Bill 620 An Act relative to health care cost transparency Neutral $0.00 N/A
Senate Bill 627 An Act to promote transparency in prescription drug prices Neutral $0.00 N/A
House Bill 4033 An Act relative to combatting addiction, accessing treatment, reducing prescriptions, and enhancing prevention Neutral $0.00 N/A
House Bill 4639 An Act establishing the Honorable Peter V. Kocot Act to enhance access to high quality, affordable and transparent healthcare in the Commonwealth Neutral $0.00 N/A
Senate Bill 2573 Affordable Health Care Neutral $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
Close this page